Clobazam Dosing: Divided Doses Required for Daily Doses >5 mg
Yes, clobazam must be given in divided doses twice daily when the total daily dose exceeds 5 mg; only a 5 mg daily dose can be administered as a single dose 1.
FDA-Approved Dosing Schedule
The FDA drug label explicitly states that any daily dose of clobazam greater than 5 mg should be administered in divided doses twice daily 1. This is the definitive guidance that supersedes other considerations.
Weight-Based Dosing Requirements
For patients ≤30 kg:
- Starting dose: 5 mg daily (can be single dose)
- Day 7: 10 mg daily (must be divided twice daily)
- Day 14: 20 mg daily (must be divided twice daily)
For patients >30 kg:
- Starting dose: 10 mg daily (must be divided twice daily)
- Day 7: 20 mg daily (must be divided twice daily)
- Day 14: 40 mg daily (must be divided twice daily)
Pharmacokinetic Rationale
The requirement for divided dosing is based on the pharmacokinetics of clobazam and its active metabolite N-desmethylclobazam. These compounds require 5 and 9 days respectively to reach steady-state 1. Divided dosing helps maintain more stable serum concentrations throughout the day, which is critical for seizure control in Lennox-Gastaut syndrome.
Special Population Considerations
Elderly patients: Start with 5 mg/day (single dose), then titrate to half the standard doses shown above, administered in divided doses when exceeding 5 mg 1.
CYP2C19 poor metabolizers: Start with 5 mg/day (single dose), then titrate to half the standard doses, administered in divided doses when exceeding 5 mg, due to increased levels of the active metabolite 1.
Clinical Evidence Context
While older research studies from the 1980s examining clobazam for anxiety disorders found that single versus divided daily dosing produced similar results for anxiolysis 2, 3, these studies are not applicable to current epilepsy indications. The FDA approval for Lennox-Gastaut syndrome specifically requires divided dosing for doses >5 mg based on controlled trials that demonstrated efficacy with this regimen 1.
Critical point: The divided dosing requirement is not merely a suggestion but a specific FDA-mandated administration instruction that was part of the clinical trial design demonstrating efficacy 1.